Although YAP has been implicated in several cancers (colorectal, lung, pancreatic, and rhabdomyosarcoma13, 14, 15), its oncogenic potential was first identified and described in adult hepatocellular carcinoma (HCC)15, 16. This evidence concerns the gene YAP1 and hepatocellular carcinoma.